Topic

Articles

Nicole Richie, Global Head Health Equity and Population Science at Genentech/Roche, discusses a renewed strategy in big pharma to incorporate diversity inclusion in clinical trials.

Clinical Trial Diversity Inclusion is Becoming a Socially Responsible Initiative

Physicians share their experiences integrating research into practice.

Bringing Clinical Trials to the Point of Care

Study designs, coupled with difficulties finding, enrolling and retaining trial participants, further intensify operational challenges and prevent new treatments from getting to market. 

AI Addresses the Complexities of Cancer Trials  for Patients and Pharma

While it's important to note that there are areas where the industry can improve, there are unique opportunities of improvement for specific types of sites and the number of studies conducted there. 

Identify Opportunities to Improve Diversity Recruitment

Andaman7 and Afrisda, Inc. sign partnership agreement to support digital health implementation in Africa.

Africa Emerges as Digital Health Proving Ground

Do Oncology Clinical Trial Participants Cost More for Payers?

Centralized medical imaging providers must challenge their current processes to improve patient diversity.

Improving Clinical Trial Patient Diversity: Can Central Imaging Play a Role?

How COVID-19 blazed a new trail for greater patient inclusion.

The Many Paths of Diversity in Clinical Trials

Affirming and advancing patient engagement and digital transformation.

Contemplating the Full Measure of Pandemic Response

The role of data science, how it can help us understand patient behavior, and why digital adherence solutions are the future.

Patient Participation